Trade BNTC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Benitec Biopharma Inc. (BNTC) is trading at US$12.58, down 0.75% today as of Aug 28, 12:27 EDT. The company has a market capitalisation of US$463.1M. Over the past 52 weeks, BNTC has traded between US$9.85 and US$16.76. On Syfe you can trade BNTC with $0 commission and add it to your watchlist.
| Previous close | US$12.67 |
|---|---|
| Market cap | US$463.1M |
| 52-week range | US$9.85 – US$16.76 |
| Volume | 103.15K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Benitec Biopharma Inc.
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.
Year: 2012
Wedbush Initiates Benitec Biopharma at Outperform With $16 Price Target
Jul 28, 10:46 AM · MT Newswires
Benitec Biopharma Inc. (BNTC) stock is trading at US$12.58, -0.75% from the previous close of US$12.67.
The market cap for Benitec Biopharma Inc. (BNTC) stock is approximately US$463.1M.
The 52-week high for Benitec Biopharma Inc. (BNTC) stock is US$16.76.
The 52-week low for Benitec Biopharma Inc. (BNTC) stock is US$9.85.
Benitec Biopharma Inc. (BNTC) does not currently pay a dividend.
Stay on top of BNTC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
